Poster 2009
J. M. Wagner, J. Schemies, K. Huber, U. Uciechowska, T. Rumpf, F. Bracher, W. Sippl, M. Jung.
New inhibitors of NAD+ dependent histone deacetylases (sirtuins) with cellular activity.
ICC on Sirtuins 2009,
Barcelona, 22.-23.10.2009
M. Jung, M. Schmitt, J. Schemies, R. Rumpf, J. Wagner, U. Uciechowska, W. Sippl.
Thiobarbiturate inhibitors of NAD+ dependent histone deacetylases (sirtuins).
Frontiers in Medicinal Chemistry
Barcelona, 04.-06.10.2009
U. Uciechowska, J. Schemies, M. L. Schmitt, M. Jung, W. Sippl.
Prediction of ligand binding free energies of novel thiobarbiturates to the human NAD+ dependent histone deacetylase Sirt2.
Jahrestagung der Deutschen Pharmazeutischen Gesellschaft.
Jena, 29.09. - 01.10. 2009.
G. Al-Mazaideh, W. Sippl, M. Schmitt
Synthesis and development of new potential ATP-competitive Myt1 kinase inhibitors
Jahrestagung der Deutschen Pharmazeutischen Gesellschaft.
Jena, 29.09. - 01.10. 2009.
C. Göllner, C. Philipp, B. Dobner, W. Sippl, M. Schmidt.
New glycoglycerolipid-derivatives as potential lead structures for Myt1 kinase inhibitors
Jahrestagung der Deutschen Pharmazeutischen Gesellschaft.
Jena, 29.09. - 01.10. 2009.
C. Philipp, C. Göllner, H.H. Rüttinger, W. Sippl, M. Pietzsch, M. Schmidt.
Generation of Myt1 kinase and development of Myt1 kinase bioassays
Jahrestagung der Deutschen Pharmazeutischen Gesellschaft.
Jena, 29.09. - 01.10. 2009.
F. Ulrich, C. Jungandreas, M. Krug, W. Sippl, A. Hilgeroth
Lead scaffold formation and docking studies of novel receptor tyrosine kinase inhibitors
Jahrestagung der Deutschen Pharmazeutischen Gesellschaft.
Jena, 29.09. - 01.10. 2009.
A.-T. Hauser, S. Schlimme, D. Stolfa, A. Carotti, V. Carafa, L. Altucci. W. Sippl, M. Jung.
Investigation of carbamate prodrugs of hydroxamic acid containing HDAC inhibitors.
Jahrestagung der Deutschen Pharmazeutischen Gesellschaft.
Jena, 29.09. - 01.10. 2009.
E.-M. Bissinger, A. Spannhoff, C. Pöverlein, T. Lindel, E. Metzger, R. Schüle,
W. Sippl, M. Jung.
Oroidines as new inhibitors of histone methyltransferases with indirect anti-hormone properties.
Jahrestagung der Deutschen Pharmazeutischen Gesellschaft.
Jena, 29.09. – 1.10. 2009.
S. D. Furdas, J. M. Wagner, S. Shekfeh, W. Sippl, M. Jung.
Pyridoisothiazolones as novel class inhibitors of histone acetyltransferase activity.
Jahrestagung der Deutschen Pharmazeutischen Gesellschaft.
Jena, 29.09 – 01.10.2009
R. Heinke, A. Spannhoff, E.-M. Bissinger, R. Meier, M. Jung, W. Sippl.
Virtual screening and optimization of novel arginine methyltransferase inhibitors.
Jahrestagung der Deutschen Pharmazeutischen Gesellschaft.
Jena, 29.09 – 01.10.2009.
G. Erlenkamp, C.K. Marx, M. Pietzsch, W. Sippl.
Prediciting thermostability of random mutants of microbial transglutaminase.
Jahrestagung der Deutschen Pharmazeutischen Gesellschaft.
Jena, 29.09 – 01.10.2009.
S. Shekfeh, S.D. Furdas, M. Jung, W. Sippl.
Docking study and binary classification model of isothiazolones as irreversible inhibitors of the histone acetyltransferase PCAF.
Jahrestagung der Deutschen Pharmazeutischen Gesellschaft.
Jena, 29.09 – 01.10.2009.
M. Pippel, R. Meier, W. Sippl
Development and validation of a statistical scoring function for a protein-ligand docking program
Jahrestagung der Deutschen Pharmazeutischen Gesellschaft.
Jena, 29.09 – 01.10.2009.
M. Jung, J. Schemies, U. Uciechowska, M. L. Schmitt, W. Sippl.
Novel inhibitors of NAD+ dependent histone deacetylases (sirtuins) with a thiourea structure.
3rd European Conference of Chemistry for Life Sciences
Frankfurt, 02.-05.09.2009
S. Shekfeh, S.D. Furdas, M. Jung, W. Sippl.
Docking study and binary classification model of isothiazolones as irreversible inhibitors of the histone acetyltransferase PCAF.
5th Summerschool on Drug Design
Vienna, 13. – 16.09.2009.
K. Wichapong, S. Kokpol, W. Sippl
Virtual screening study of dengue virus NS2B/NS3 protease inhibitors.
5th Summerschool on Drug Design
Vienna, 13. – 16.09.2009.
M. Pippel, R. Meier, W. Sippl
Development and validation of a statistical scoring function for a protein-ligand docking program
5th Summerschool on Drug Design
Vienna, 13. – 16.09.2009.
U. Uciechowska, J. Schemies, M. Jung, W. Sippl
Prediction of ligand binding free energies of novel thiobarbiturates to the human NAD+ dependent histone deacetylase Sirt2.
Molecular Modelling Conference
Erlangen, 06.-08.09.2009.
K. Wichapong, S. Pianwanit, W. Sippl and S. Kokpol
Molecular Dynamics Simulation and Virtual Screening for Inhibitors of Dengue Virus NS2B/NS3 Protease.
2009 ACS Meeting
Washington, USA, 16.-20.08.2009.
K. Wichapong, S. Pianwanit, W. Sippl and S. Kokpol
Search for novel inhibitors of Dengue Virus NS2B/NS3 protease by combining virtual screening and MM-PBSA binding free energy calculations
eCheminfo 2008
Oxford, UK, 06.-08.05.2009.
S. Taddese, A. Heinz, M.C. Jung, W. Sippl, A.S. Weiss, R.H.H. Neubert and
C.E.H. Schmelzer
Insights into the Cleavage Process of Elastin and its Precursor by Matrix Metalloproteinases
Gordon Research Conference Elastin & Elastic Fibers
Biddeford, ME, USA. 26.-31-07.2009
U. Uciechowska, J. Schemies, M. L. Schmitt, E.-M. Huda, M. Jung, W. Sippl Prediction of binding free energies of NAD+ dependent histone deacetylase inhibitors
5th German-Polish Symposium on Pharmaceutical Sciences
Poznan, 15.-05.-17.05.2009.